National Vaccine
Information Center

Your Health. Your Family. Your Choice.
Search Results

From the 1/14/2022 release of VAERS data:

This is VAERS ID 1745882

Government Disclaimer on use of this data

Case Details

VAERS ID: 1745882 (history)  
Form: Version 2.0  
Age: 22.0  
Sex: Male  
Location: Foreign  
   Days after vaccination:64
Submitted: 0000-00-00
Entered: 2021-09-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other       Purchased by: ?
Symptoms: Testis cancer
SMQs:, Non-haematological malignant tumours (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data:
CDC Split Type: DEPFIZER INC202101215945

Write-up: Epididymis tumor appeared on both sides in early September; This is a spontaneous report from a non-contactable consumer downloaded from the regulatory authority-WEB. The regulatory authority report number is DE-PEI-202100188805. A 23-year-old male patient received BNT162B2 (COMIRNATY), via an unspecified route of administration on 29Jun2021 (Batch/Lot Number: FE6975) at 22 years of age, as dose 2, single for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. The patient previously received 1st dose of BNT162B2 (COMIRNATY) on 18May2021 (lot number: 1C0061A) for COVID-19 immunisation. The patient experienced epididymis tumor appeared on both sides (Testicular cancer) in early Sep2021. The outcome of the event was unknown. This report was reported serious - other. Relatedness of drug to reaction/event was D. Unclassifiable. No follow-up attempts are possible. No further information is expected.

New Search

Link To This Search Result:

Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166